Topical application with a new NF-kappaB inhibitor improves atopic dermatitis in NC/NgaTnd mice. [electronic resource]
Producer: 20070405Description: 855-63 p. digitalISSN:- 1523-1747
- Administration, Topical
- Animals
- B-Lymphocytes -- metabolism
- Benzamides -- administration & dosage
- Cell Lineage
- Cell Proliferation -- drug effects
- Cells, Cultured
- Dermatitis, Atopic -- pathology
- Down-Regulation
- Immunocompetence
- Immunoglobulin E -- biosynthesis
- Immunosuppressive Agents -- pharmacology
- Keratinocytes -- pathology
- Male
- Mast Cells -- drug effects
- Mice
- Mice, Inbred Strains
- NF-kappa B -- antagonists & inhibitors
- Neurites -- drug effects
- Ointments
- Severity of Illness Index
- Skin -- drug effects
- Spleen
- Tacrolimus -- pharmacology
- Th2 Cells -- metabolism
- Tumor Necrosis Factor-alpha -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.